MDR-TB: Clinical Trials

1 trial for MDR-TB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow MDR-TB: new trials by email Literature Review of MDR-TB trials Research Report on MDR-TB

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
Vγ2Vδ2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB - MDR-TB, Immunotherapy
Phase 4RecruitingShanghai Pulmonary Hospital, Shanghai, China302022-08-032022-08-10

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Mycobacterium Infections (1)  ·  Tuberculosis (1)

Interventions

Clinical Protocols (1)  ·  Drug Combinations (1)

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

China (1)